搜尋結果
How Drug Companies Stifle Competition With ‘Product Hopping’
Forbes· 1 日前In 2014, drugmaker Forest Laboratories and its parent, Actavis, had a $28 billion problem. ...
Lula's ambitions for Petrobras hemmed in by new rules
Reuters· 2 日前In her first public statement since appointed as CEO, Chambriard said in a post on LinkedIn on ...
‘Pax Economica’ Review: When Free Trade Was Progressive
The Wall Street Journal· 5 日前Richard Cobden (1804-65) was a Victorian radical, a hugely influential British politician and ...